State Cannabis Law Changes Taking Effect October 2026: What to Know

Executive summary

October 1 is one of the busiest effective dates on the state cannabis calendar, and the 2026 batch, covering Connecticut, Maryland, California and other states, lands weeks before a federal hemp deadline and while marijuana rescheduling is still unresolved. The Marijuana Herald published a roundup on September 30, 2026 headlined "Marijuana Law and Regulatory Changes Taking Effect October 1 in Connecticut, Maryland, California and More." This hub uses that roundup as its trigger and builds the durable reference around it.

Many states start their fiscal year on July 1 or October 1, and legislatures often write bills to take effect on those dates. Cannabis statutes and rules passed in spring sessions therefore tend to cluster on Oct. 1. Operators then face new tax rates, packaging rules, license requirements, testing standards and enforcement priorities all at once.

This page does three things. It explains why October effective dates matter and how to read them. It gives the legal and market history of the three named states: California's Proposition 64 (2016), Connecticut's Public Act 21-1 (2021) and Maryland's Question 4 (2022). And it lays out the federal overlay, including 21 U.S.C. § 812 scheduling, Section 280E of the tax code and the intoxicating-hemp restrictions scheduled to take effect in November 2026.

CannIntel will append dated update sections as individual provisions are verified against statutory text and regulator notices. Until a provision is verified, treat any summary, including the roundup headline, as a lead to check, not a compliance instruction.

Why this matters

October effective dates change operating costs, product eligibility and legal exposure for licensed businesses and patients on the same day, with little room for a phased rollout.

Three groups carry most of the risk.

• Multi-state operators (MSOs). An MSO running in California, Connecticut and Maryland must reconcile three different tax structures, track-and-trace systems and labeling regimes. A change that takes effect Oct. 1 in all three forces simultaneous updates to point-of-sale software, packaging runs and employee training.
• Independent licensees and social equity operators. Smaller businesses have less capacity to absorb rule changes and often learn of them late. Connecticut and Maryland both built social equity programs into their adult-use laws, so licensing and compliance changes land hard on those cohorts.
• Consumers and patients. Possession limits, purchase limits, home-grow rules and medical-program terms affect everyday behavior. Medical patients in particular are exposed when states fold medical programs into adult-use frameworks.

The dollar scale is large. California's legal market is the biggest in the country, and its tax policy has been a central industry fight since AB 195 (2022) restructured excise collection. Maryland raised its adult-use sales tax from 9% to 12% effective July 1, 2025. Connecticut layers a sales tax, a potency-based tax and a local tax on adult-use purchases. Each rate change feeds directly into retail price, wholesale pricing pressure and illicit-market competition.

Background and history

The state cannabis map was built by ballot measures and legislation over 30 years, and each of the three named states reached its current framework through a different political path.

1996: California opens the medical era

California voters approved Proposition 215, the Compassionate Use Act, in November 1996. It made California the first state to allow medical cannabis. The federal government did not recognize the change, and the conflict between state and federal law that still defines the industry started here.

2005: Gonzales v. Raich

In Gonzales v. Raich (2005), the U.S. Supreme Court held that Congress's Commerce Clause power reaches homegrown, medically used cannabis under the Controlled Substances Act. The ruling confirmed that state legalization does not displace federal prohibition. It is the legal reason every state program exists at the federal government's tolerance, not by right.

2013 to 2014: federal non-interference

The Justice Department's 2013 Cole Memorandum set enforcement priorities that let state-regulated markets expand. Congress then adopted the Rohrabacher-Farr appropriations rider (now often called Joyce-Blumenauer) in the 2014 spending bill. It bars the Justice Department from using funds to interfere with state medical cannabis programs. The rider must be renewed through appropriations, which ties federal fiscal-year deadlines, including Oct. 1, to cannabis policy.

2016 to 2018: California adopts adult use

California voters passed Proposition 64 in November 2016. Adult-use retail sales began January 1, 2018. The law set a baseline of 28.5 grams of flower and 8 grams of concentrate for adults 21 and over. It created a licensing system now run by the Department of Cannabis Control, which consolidated earlier agencies in 2021. California then spent years adjusting a tax structure that operators said strained the licensed market against illicit competition.

2018: hemp is carved out

The 2018 Farm Bill (codified at 7 U.S.C. § 1639o and following) removed hemp with no more than 0.3% delta-9 THC by dry weight from the Controlled Substances Act. The change produced a gray market in intoxicating hemp-derived products, which state regulators and licensed marijuana operators have contested ever since.

2021: Connecticut legalizes

Connecticut enacted adult-use legalization through Public Act 21-1 (Responsible and Equitable Regulation of Adult-Use Cannabis, or RERACA), effective July 1, 2021. Adults 21 and over could possess up to 1.5 ounces on their person and 5 ounces in a locked container at home or in a vehicle trunk. Home cultivation was authorized from October 1, 2021, a date that shows how Connecticut uses Oct. 1 as a milestone. Adult-use retail sales began January 10, 2023, and the Social Equity Council oversees equity licensing.

2021 to 2022: New York sets a competing template

New York enacted the Marihuana Regulation and Taxation Act on March 31, 2021, with first adult-use sales in December 2022. Its slow licensing rollout became a case study that neighboring states, Connecticut and New Jersey among them, referenced when designing their own programs.

2022 to 2023: Maryland's ballot path

Maryland voters approved Question 4 in November 2022, a constitutional amendment legalizing adult use. Possession became legal July 1, 2023, and licensed adult-use sales began the same day through existing medical operators. Adults may possess up to 1.5 ounces and grow two plants. The Maryland Cannabis Administration took over regulation from the earlier medical commission, and the state has since pursued social equity licensing rounds.

2023 to 2024: Ohio and the federal rescheduling track

Ohio voters approved Issue 2 in November 2023, with adult-use sales starting in August 2024. In August 2023, the Department of Health and Human Services recommended moving marijuana from Schedule I to Schedule III. In May 2024, the DEA published a notice of proposed rulemaking (NPRM) to do so. An administrative law judge (ALJ) hearing process followed but stalled in early 2025.

2025 to 2026: tax relief, hemp ban and executive action

California moved in 2025 to roll back its scheduled excise tax increase. Under AB 564, the cultivation-and-retail excise tax reverted to 15% in place of the 19% rate set to apply after July 1, 2025. Verify the exact effective dates and sunset against the enacted text. In November 2025, Congress enacted a federal funding law that redefines hemp to exclude most intoxicating hemp-derived products. As enacted, it takes effect 365 days after signing, in mid-November 2026. In December 2025, President Trump signed an executive order directing the Attorney General to expedite marijuana rescheduling. Final outcomes on rescheduling should be confirmed against Federal Register notices.

Key players

Regulators, federal agencies, operators and advocates each shape what actually takes effect on October 1 and how aggressively it is enforced.

State regulators

California's Department of Cannabis Control writes licensing, testing and packaging rules. Connecticut's Department of Consumer Protection administers adult-use and medical licensing, with the Social Equity Council reviewing equity applicants. The Maryland Cannabis Administration oversees licenses, compliance and the equity program. Each agency publishes notices on emergency rules and effective dates, and those notices are the primary source for operators.

Federal agencies

The DEA controls scheduling under 21 U.S.C. § 811 and holds the NPRM record. The FDA conducts the scientific and medical review behind HHS recommendations and has a growing role in hemp-derived cannabinoids. The Treasury Department and IRS administer Section 280E, which denies ordinary business deductions to businesses trafficking in Schedule I or II substances. Rescheduling to Schedule III would remove most 280E exposure.

Operators

Large MSOs operate across the three states, while thousands of single-site licensees make up most of the market. Their interests diverge. MSOs generally favor federal rescheduling and uniform rules. Independents often prioritize local control, tax relief and protection from consolidation.

Advocates and opposition

The Marijuana Policy Project, NORML and the Drug Policy Alliance push for expansion, equity funding and expungement. Opposition comes from groups such as Smart Approaches to Marijuana, which has argued for stricter potency and marketing limits, and from some public-health and law-enforcement associations. Hemp producers and alcohol-industry groups are active in the intoxicating-hemp fight.

Legal and regulatory framework

State cannabis law operates inside a federal prohibition, so every October change must be read against the Controlled Substances Act, tax law and appropriations riders.

• Controlled Substances Act, 21 U.S.C. § 801 and following. Marijuana is Schedule I under 21 U.S.C. § 812(c). Rescheduling proceeds under § 811 through formal rulemaking with notice and opportunity for hearing.
• Internal Revenue Code § 280E. Bars deductions and credits for trafficking in Schedule I or II substances. This is the single largest federal cost for state-licensed operators.
• Appropriations riders. The medical-cannabis protection rider requires periodic renewal. Federal fiscal years begin October 1, so lapses and continuing resolutions are a recurring risk.
• 2018 Farm Bill. Defines hemp at 0.3% delta-9 THC. The November 2025 amendment narrows that definition and limits total THC per finished product. Confirm thresholds in the enacted text.
• Federalism. Gonzales v. Raich keeps federal authority intact, while anti-commandeering doctrine means states are not required to enforce federal cannabis prohibition.

At the state level, three layers apply: the enabling statute (Prop 64, Public Act 21-1, Maryland's Question 4 and implementing legislation), agency regulations, and local ordinances. California lets cities and counties ban or limit retail. Connecticut and Maryland also allow municipal zoning input. An Oct. 1 change can therefore originate in any of the three layers, and operators should check each.

State-by-state breakdown

California, Connecticut and Maryland share adult-use legalization but differ sharply in tax design, possession limits and home-grow rules.

State	Adult-use origin	Retail sales began	Possession limit (adults 21+)	Home grow
California	Prop 64, Nov. 2016	Jan. 1, 2018	28.5 g flower; 8 g concentrate	Up to 6 plants per residence
Connecticut	Public Act 21-1, effective July 1, 2021	Jan. 10, 2023	1.5 oz on person; 5 oz locked	Up to 6 plants (3 mature) per person, 12 per household, since Oct. 1, 2021
Maryland	Question 4, Nov. 2022	July 1, 2023	1.5 oz flower (with concentrate and edible equivalents)	2 plants per adult, 4 per household

California

California is the largest and most mature market, and its regulatory churn is constant. Key October-relevant topics include excise tax rates after AB 564, Department of Cannabis Control rulemaking on packaging and testing, local retailer permitting, and the interplay with hemp-derived products. Operators should check the Department of Cannabis Control's regulatory-update page and the Office of Administrative Law for rules filed with an Oct. 1 effective date. Confirm current rates through the California Department of Tax and Fee Administration.

Connecticut

Connecticut keeps a tightly managed license structure with a social equity mandate. Its adult-use tax stacks a 6.35% sales tax, a 3% municipal tax and a potency-based excise tax, which means price changes follow product potency. Oct. 1 has served as a Connecticut effective date before (home-grow in 2021), and the General Assembly frequently sets it for fiscal-year-aligned provisions. Any Oct. 1, 2026 change should be confirmed in the Public Act text and the Department of Consumer Protection's guidance.

Maryland

Maryland runs a dual medical and adult-use system administered by the Maryland Cannabis Administration. The adult-use tax rose to 12% on July 1, 2025. The state's equity licensing rounds, local zoning fights and medical-program transition remain the main sources of regulatory change. Check Maryland General Assembly session laws, many of which take effect on July 1 or October 1.

Other states to watch

Other states commonly produce October changes: Ohio, which has been amending its Issue 2 framework through the legislature, New York, where the Office of Cannabis Management continues to revise licensing rules, and Massachusetts, where the Cannabis Control Commission regularly issues regulation updates. CannIntel will add verified entries here once each provision is confirmed against primary text.

Market and business implications

Tax changes and compliance shifts move operator margins faster than any single product trend, so Oct. 1 effective dates function as quarterly earnings events for the sector.

CannIntel's framework for reading any October change sorts it into four categories, each with a different financial effect:

1. Price-setting changes (taxes, fees, price floors). These move retail pricing and pass through to wholesale within one to two quarters. A tax cut, like California's reversion to 15%, can widen retail margins or let operators lower shelf prices, depending on local competition.
2. Cost-of-goods changes (testing, packaging, labeling). These hit producers and processors first and are often fixed costs that favor scale. MSOs absorb them more easily than craft operators.
3. Market-structure changes (license caps, equity rounds, local-control rules). These alter supply and competition over years, not quarters.
4. Product-eligibility changes (potency limits, hemp-derived product rules, flavor or marketing restrictions). These can strand inventory and require reformulation.

Capital flows follow regulatory certainty. Rescheduling to Schedule III would remove 280E pressure for state-licensed operators, which analysts wid